Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fabio Alves Teixeira has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enteral and Partial Parenteral Nutritional Support in Two Hospitalised Giant Anteaters ( Myrmecophaga tridactyla )

    by Livia Perles, Camila Goloni, Brana Sanctos Alo Bonder, Fabio Alves Teixeira, Stephanie de Souza Theodoro, Aulus Cavalieri Carciofi, Karin Werther

    Background: Information regarding enteral and parenteral nutritional support in hospitalised giant anteaters ( Myrmecophaga tridactyla ) is limited. Objectives: To describe the nutritional management and clinical outcomes of two giant anteaters receiving different forms of nutritional support following traumatic brain injury. Methods: Clinical records of two free‐ranging giant anteaters admitted after traumatic accidents were retrospectively reviewed. Clinical presentation, nutritional interventions, administration procedures, complications and outcomes were evaluated. One animal received enteral nutrition through a nasoesophageal tube, whereas the other received partial parenteral nutrition (PPN). Results: The first anteater presented with a skull fracture and cerebral haemorrhage and was unable to feed voluntarily. Nasoesophageal feeding was provided for 7 days and was not associated with observed aspiration or nasal complications. Voluntary feeding subsequently resumed, and the animal was discharged after 2 months. The second anteater presented comatose following head trauma and received PPN after 4 days without voluntary food intake. Hyperglycemia occurred during administration and was managed by reducing the infusion rate. Voluntary food intake resumed on the second day of PPN. However, the animal died 15 days after admission from complications attributed to the head trauma. Conclusions: Nasoesophageal feeding and PPN were technically feasible in these two hospitalised giant anteaters. These cases provide preliminary clinical information on alternative nutritional support in this species but do not establish the safety or efficacy of either technique. Trial Registration: This retrospective descriptive case series did not involve a prospective clinical trial requiring registration.

  • Open Access

    Dapagliflozin in poorly controlled canine diabetes mellitus - case report

    by J.S. Camargo, S.L. Górniak, F.T. Alves, M.M. Jericó

    Sodium-glucose cotransporters 2 inhibitors (SGLT2i) are a class of drugs used in human medicine and, more recently, in feline medicine as adjunctive therapy for diabetes mellitus (DM). Their mechanism of action promotes urinary excretion of 90 to 97% of the glucose filtered by the kidneys, aiming to improve glycemic control, and reduce insulin applications and the risk of hypoglycemia. In diabetic dogs, which are mostly insulin-deficient, the literature lacks studies evaluating the effects of these drugs, with no data regarding dapagliflozin. This report describes the case of an 11-year-old spayed female English Mastiff, with DM, initially treated with degludec insulin. Due to poor glycemic control, dapagliflozin, an SGLT2i, was introduced at doses of 5 to 10 mg/dog, administered orally every 24 hours. The therapy resulted in no adverse effects, with reductions in blood glucose levels and required insulin doses. Although SGLT2i are not approved for use in dogs by any regulatory agency worldwide and may be associated with potential adverse effects, such as hypoglycemia and euglycemic diabetic ketoacidosis, dapagliflozin was well tolerated in the case reported here, contributing to improved disease management.

  • Top Cited Papers
    Open Access

    Household survey on prevalence and risk factors for obesity in owned cats from Central Brazil

    by Danilo Conrado Silva, Mariana Yukari Hayasaki Porsani, Aparecido Divino da Cruz, Erika Figueiredo Pereira, Klayto José Gonçalves dos Santos, Lysa Bernardes Minasi, Vitória Alvarenga Nunes, Alex Silva da Cruz, Fabio Alves Teixeira

    Few studies have conducted the prevalence of obesity in cat populations and the associated risk factors by assessing cats in their homes, regardless of whether they had visited a veterinary hospital. Moreover, such studies are scarce in Latin America, and, to date, few census-based, in-home epidemiological assessment of feline obesity has been conducted in Brazil. This study aimed to estimate the prevalence of obesity in owned cats in the metropolis of Goiânia, Goiás, Brazil, and to assess the presence of risk factors related to the animals, their owners, the home environment, and cat management practices. A cross-sectional study was conducted with 188 cats and their owners, using geographically stratified household sampling. The animals were categorized based on body condition score (BCS) as underweight, ideal weight, overweight, or obese, and prevalence rates were calculated. The BCS was investigated for its association with animal, owner, environmental, and management characteristics using the Kruskal-Wallis test (α = 5%). Subsequently, characteristics with p ≤ 0.05 were analyzed as potential risk factors for overweight or obesity using binary logistic regression. Kappa analysis was used to determine the agreement between the BCS determined by veterinarians and the owners’ perception of their cats’ body condition. The prevalence of overweight and obesity in cats was 28.7%. Factors related to age and activity level, type of household, as well as the owners’ education and occupation, were identified as risk factors for the development of overweight or obesity in the study cat population. Additionally, protective factors against overweight and obesity were identified, including the number of cats in the household, the location of the household, and the owners’ perception of their own diet. The agreement between the actual BCS of the animals and the owners’ perception of their cats’ body condition was considered low.


  • Open Access

    Effects of a Saccharomyces cerevisiae Fermentation Product on Diet Palatability and Feline Intestinal Health, Immunity, and Microbiome

    by Patricia Eri Ishii, Fabio Alves Teixeira, Ching-Yen Lin, Syed Ali Naqvi, Maria I. Sardi, Sharon A. Norton, Jessica K. Jarett, Ehsan Khafipour, Nolan Frantz, Anirikh Chakrabarti, et al.

    This study evaluated the effects of adding a Saccharomyces cerevisiae fermentation product (SCFP) to adult cat diets on palatability, intestinal health, nutrient digestibility, immune parameters, and the fecal microbiome over 42 days. Sixty-three healthy Domestic Short-hair cats were randomized to three diets: a control diet (CD) without SCFP, or the same diet containing 1.0% or 2.0% SCFP, targeting daily intakes of 150 or 300 mg/kg body weight, respectively. Body weight and blood parameters remained within reference ranges across all groups. Stool quality was largely not affected, although compared with controls, SCFP-supplemented cats had slightly firmer stools at day 21, and increased fecal pH. Shotgun metagenomic sequencing revealed that microbiome diversity remained steady in SCFP-fed cats, whereas diversity in the control group declined over time. Fecal immunoglobulin A concentrations were lower in cats supplemented with SCFP at 150 mg/kg BW by the end of the study, and positive shifts in the circulatory leukocyte profile were observed at both inclusion levels. Apparent total tract macronutrient digestibility did not differ among groups. Palatability tests showed diets with SCFP were generally preferred, indicating a potential benefit for commercial feline feeds, particularly at the 150 mg/kg BW level, which was preferred over 300 mg/kg BW. Overall, these findings suggest that SCFP can act as a functional ingredient in feline nutrition to maintain microbial diversity and enhance diet acceptance without compromising digestibility.


  • Open Access

    Evaluation of the Short-Term Effects of Mirtazapine on Appetite Stimulants in Dogs: A Retrospective Study and a Placebo-Controlled Trial

    by Stephanie S. Theodoro, Maria Eduarda G. Tozato, Thais O. Ximenes, Lara M. Volpe, Camila Baptista da Silva, Fabio A. Teixeira, Aulus C. Carciofi

    Anorexia and hyporexia are common clinical signs in dogs with acute or chronic illnesses, often requiring targeted nutritional interventions. Mirtazapine, an orexigenic drug widely used in cats, has limited evidence supporting its use in dogs. This study evaluated mirtazapine’s efficacy as an appetite stimulant in dogs using a two-part approach: (1) a retrospective analysis of 107 clinical cases comparing dogs that received mirtazapine to untreated controls; and (2) a prospective, placebo-controlled, double-blind crossover trial involving 25 dogs. In the retrospective analysis, dogs treated with mirtazapine were significantly more likely to resume voluntary food intake (OR = 3.06) and had less weight loss compared to controls. In the prospective trial, mirtazapine significantly increased food acceptance on the first day (100% vs. 63.6%, p = 0.03), with no adverse effects observed. However, the effect was not maintained on the second day, possibly due to residual drug activity or clinical improvement. Latency to feeding averaged 120 min post-administration. Mirtazapine was safe and well tolerated, even in dogs with comorbidities. These findings support the short-term use of mirtazapine as a second-line appetite stimulant in dogs when enteral feeding is not feasible.


  • Open Access

    Nutritional Factors Related to Canine Gallbladder Diseases—A Scoping Review

    by Fabio Alves Teixeira, Kathleen Moira Aicher, Ricardo Duarte

    Gallbladder mucocele, cholelithiasis, choledocholithiasis, and cholecystitis are significant contributors to morbidity and mortality in dogs. The exact etiology of these conditions remains poorly understood, though various factors, such as endocrinopathies, dyslipidemia, and impaired gallbladder motility, have been suggested as potential contributors. Surgical intervention has been described as the first choice of treatment when biliary rupture or obstruction is suspected; however, medical management may be an important part of therapeutic or preventative strategy. Reports of medical management typically involve the use of a choleretic used to stimulate the flow of bile into the duodenum or substances that act as a “hepatoprotective” agent such as S-adenosylmethionine. In people, some nutrients appear to modify bile flow and are used as agents in the prevention and treatment of these conditions in the gallbladder. This paper provides a review of the literature about possible nutritional factors involved in the pathogenesis and treatment of canine gallbladder mucocele and cholelithiasis. Opportunities for the prevention and treatment of common biliary diseases in dogs may include the reduction of dietary fat, control of hyperlipidemia with omega-3 and fiber supplementation, ensuring an adequate supply of amino acids such as methionine and tryptophan, and the evaluation of vitamins such as vitamin D.


  • Open Access

    The Impact of a Hypoallergenic Diet on the Control of Oral Lesions in Cats: A Case Report

    by Luiza da Silva, Taís Martins, Mariana Yukari Hayasaki Porsani, Fabio Alves Teixeira

    Feline stomatitis or gingivostomatitis is a chronic inflammatory condition affecting approximately 0.7% of patients. The cause is multifactorial, involving infectious agents, genetic factors, and environmental influences. Therapeutic strategies include pharmacological and surgical interventions to controlling inflammation and enhancing patient quality of life. There are discussions in the literature regarding the potential involvement of adverse food reactions as a contributing factor to oral cavity lesions, without clear evidence. This case report describes the control of gingivostomatitis with a hypoallergenic diet in a cat that had oral lesions and who was refractory to conventional treatment with prednisolone and cyclosporine, even after periodontal treatment and partial tooth extraction. After 30 days of dietary change, there was complete remission of the lesions. The animal was then re-exposed to the previous food, with new lesions appearing after 7 days. Upon returning to the hypoallergenic food, there was new remission of the lesions. This report suggests that food sensitivity may play a role in the control of feline gingivostomatitis, as periods of hypoallergenic diet coincided with the remission of the condition, even without changes in medication. It reinforces the importance of investigating adverse food reactions as clinical signs in the oral cavity of cats.


  • Open Access

    Microbiota in Mild Inflammatory Bowel Disease (IBD) Can Be Modulated by Beta-Glucans and Mannanoligosaccharides: A Randomized, Double-Blinded Study in Dogs

    by Andressa Rodrigues Amaral, Mariana Fragoso Rentas, Thais Caroline Taveira Rosa, Thais Araújo Esteves Pereira, Pedro Henrique Marchi, Fabio Alves Teixeira, Fernando de Oliveira Roberti Filho, Thaila Cristina Putarov, Bruno Cogliati, Thiago Henrique Annibale Vendramini, et al.

    Inflammatory bowel disease (IBD) in dogs is the most common chronic gastrointestinal disease in dogs. Its etiology evolves an aberrant immunological response towards food antigens and indigenous bacteria in the gut bacteria and, consequently, dysbiosis. Prebiotics provide substrates for the growth of beneficial bacteria and promote the production of beneficial fermentation products. This study aimed to evaluate the effects of oral supplementations of beta-glucans and mannanoligosaccharides (MOSs) over 60 days in fecal microbiota and fecal concentrations of fermentation products in dogs with mild IBD. Eighteen dogs with mild IBD were divided into three experimental groups in a blinded and randomized manner: A—dogs received 0.1% of a beta-glucan-based prebiotic, B—dogs received 0.1% of a MOS + beta-glucan-based prebiotic, and C—dogs received 0.1% of a placebo. Fecal microbiota was analyzed using the latest generation 16S rRNA sequencing (Illumina®). Relative abundances of each taxon were analyzed using a generalized linear model, and fermentation products using a mixed model. A significance level of p was used. The prebiotics positively modulated the bacterial population of Firmicutes and Bacteroidetes. Treatment A improved alpha diversity and populations of beneficial bacteria. Beta-glucan supplementation for 60 days had beneficial effects on modulating intestinal microbiota in dogs with mild IBD.


  • Retrospective investigation of the energy requirements for weight loss and weight maintenance after weight loss programme in obese dogs

    by Fabio Alves Teixeira, Vivian Pedrinelli, Mariana Yukari Hayasaki Porsani, Brana Sanctos Alo Bonder, Ana Beatriz Fasolai, Marcio Antonio Brunetto

    Obesity is a highly prevalent disease in dogs and is characterized by the excessive accumulation of adipose tissue that results in metabolic changes. Its treatment is based on a negative energy balance focusing on energy restriction. However, there are few studies in dogs that assessed the energy intake needed for adequate weight loss and to weight maintenance afterward. The aim of this study was to evaluate data about the treatment of canine obesity, with emphasis on energy restriction to induce weight loss and to maintain body weight (BW) and ideal body condition after weight loss. This was a retrospective study in which records of obese dogs from a veterinary teaching hospital were assessed between 2014 and 2020. Sixteen dogs were considered in the study according to inclusion and exclusion criteria and 10 of these participated in the maintenance phase after weight loss. The animals lost a mean of 23.2% their initial weight in a mean of 422 days. The mean weekly weight loss rate was 0.58% of BW, and the mean daily energy intake for weight loss was 59 kcal/kg current BW0.75. When the target BW was considered, which was defined as the current weight minus 10% for every point in the body condition score scale above 5, the mean energy for weight loss was 71 kcal/kg target BW0.75. In the maintenance phase, the animals were assessed for a mean of 134 days. The mean energy intake to maintenance BW was 70 kcal/kg BW0.75. The lower energy requirement of obese dogs during and after weight loss can work as an alert for the formulations of therapeutic weight loss diets to contain a high nutrient density focusing on the wellbeing, health, and quality of life of obese dogs, not just for the weight loss phase, but a diet for the weight maintenance phase.


  • Open Access

    Hepatic arterioportal malformation in a dog - case report

    by P.S. Yogi, F.A. Teixeira, B.M.P. Coelho, D.M.N. Simões, A.M. Hayashi, G.C.F. Patricio, M.A. Brunetto, J.M. Matera, C.A.B. Lorigados

    Arterioportal communications are complex hepatic vascular abnormalities. These are rarely seen in dogs and typically manifest as neurological, gastrointestinal, and developmental changes. This report describes clinical, laboratory and imaging findings associated with hepatic arterioportal malformation in a male Shih-Tzu dog aged 12 months. The diagnosis was achieved using computed tomographic angiography. The therapeutic approach selected consisted of palliative medical management (diuretics) combined with dietary protein restriction (3.6 g/100 kcal) provided by hepatic diet and gut activity modulation using lactulose. Surgical intervention was not recommended due to the complexity of vascular changes and portal hypertension. Despite initial clinical improvement, the patient died of disease-related complications seven months after diagnosis. Computed tomographic angiography was vital for accurate diagnosis and treatment selection, that needs to be more investigated.